IMMUNOFORGE
ImmunoForge is a developer of a new drug intended for treating sarcopenia and cancer. The company has a solution for sarcopenia based on its drug repurposing patents as well as a strong kinase inhibitor pipeline for genomically defined rare cancers, such as chronic myelogenous leukemia, enabling patients to get cured quickly.
IMMUNOFORGE
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-05-29
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.immunoforge.com
Total Employee:
11+
Status:
Active
Contact:
+82-70-7721-0755
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Font Awesome Apache Mobile Non Scaleable Content Google Apps For Business Sectigo SSL Sectigo Domain SSL
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Spinogenix
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Current Employees Featured
Founder
Investors List
Quantum Ventures Korea
Quantum Ventures Korea investment in Venture Round - ImmunoForge
Official Site Inspections
http://www.immunoforge.com
- Host name: 183.111.169.45
- IP address: 183.111.169.45
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "ImmunoForge"
ImmunoForge | ์ด๋ฎค๋ ธํฌ์ง
๊ทผ๊ฐ์์ฆ, ํ์ ํญ์์ , BCR-ABL, T315I, RET, FGFR4, KIT, CSF1R, sarcopenia, targeted cancer agentsSee details»
์ด๋ฎค๋ ธํฌ์ง - ImmunoForge
Immunoforge specializes in novel drug development with pipelines based on half-life extension platform technology. Froniglutide. Pemziviptadil. PF1805. PF1806. PF1807. PF1802. PF1803. โฆSee details»
ImmunoForge - Crunchbase Company Profile & Funding
ImmunoForge is a developer of a new drug intended for treating sarcopenia and cancer. The company has a solution for sarcopenia based on its drug โฆSee details»
ImmunoForge | ์ด๋ฎค๋ ธํฌ์ง
Immunoforge specializes in novel drug development with pipelines based on half-life extension platform technology. Home > Contact > Head Office (KOR) Head Office (KOR) ADDRESS โฆSee details»
ImmunoForge Company Profile 2024: Valuation, โฆ
ImmunoForge General Information Description. Operator of a drug development and pharmaceutical company intended to develop drugs for treating sarcopenia and cancer. The company's drugs specialize in targeting Duchenne muscular โฆSee details»
ImmunoForge Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ImmunoForge Inc. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
Immunoforge Co. Ltd. - Drug pipelines, Patents, Clinical trials
Explore Immunoforge Co. Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 6 news, Disease Domain:Nervous System Diseases, Endocrinology and โฆSee details»
ImmunoForge - Products, Competitors, Financials, Employees ...
ImmunoForge is a pharmaceutical company with a focus on the development of new drugs based on long-acting technology. The company offers solutions that extend the half-life of drugs, โฆSee details»
ImmunoForge: Contact Details and Business Profile - RocketReach
ImmunoForge is a Biotechnology, Drug Discovery, and Health Care company located in Seoul, Seoul with $5.00 Million in revenue and 27 employees. Find top employees, contact details โฆSee details»
ImmunoForge - Company Profile - Tracxn
Oct 23, 2024 ImmunoForge ranks 115th among 225 active competitors. 74 of its competitors are funded while 61 have exited. Overall, ImmunoForge and its competitors have raised over โฆSee details»
์ด๋ฎค๋ ธํฌ์ง - ImmunoForge
2020 Dec. PF1801 receives US FDA ODD for DMD indication. Aug. Raises 6 billion KRW for Bridge funding (approx. 5.4M USD) Selected for The Ministry of Trade, Industry and Energy's โฆSee details»
ImmunoForge - Overview, News & Similar companies - ZoomInfo
Oct 27, 2021 ImmunoForge is a company co-founded in 2017 by Dr.Sung-Min Ahn, the head of the Gachon Genetic Science Research Institute at Gachon University Gil ...See details»
ImmunoForge Company Profile - Office Locations, Competitors
ImmunoForge has 1 employees across 2 locations. See insights on ImmunoForge including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
ImmunoForge Co. Ltd. - BioCentury Company Profiles - BCIQ
Jun 4, 2021 ImmunoForge Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
ImmunoForge - Crunchbase
ImmunoForge is a developer of a new drug intended for treating sarcopenia and cancer.See details»
ImmunoForge - VentureRadar
We are proud to offer Contract Development and Manufacturing Organization (CDMO) services for biopharmaceutical companies to propel your important monoclonal antibody molecules โฆSee details»
ImmunoForge - Contacts, Employees, Board Members, Advisors
Organization. ImmunoForge . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. โฆSee details»
ImmunoForge | ์ด๋ฎค๋ ธํฌ์ง
ImmunoForgeโs proprietary technology platform for modulating pharmacokinetics has extensive clinical and pre-clinical experience. ELP is based on a naturally-occurring amino acid โฆSee details»
ImmunoForge - Tech Stack, Apps, Patents & Trademarks
Organization. ImmunoForge . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 13. ... The โฆSee details»
ImmunoForge | ์ด๋ฎค๋ ธํฌ์ง
Immunoforge specializes in novel drug development with pipelines based on half-life extension platform technology. Home > Pipeline > Pipeline; Main Pipelines. Identification Indication โฆSee details»